{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:50:55Z","timestamp":1792601455227,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Spinal dysraphism (SD) is a general term used to refer to developmental abnormalities of the spine that involves many clinical conditions including myelomeningocele (MMC). In these patients, neurogenic bladder (NB) is a common and predisposing factor for renal damage; the most frequently used approach to manage this situation is based on clean intermittent catheterization (CIC) and anticholinergic drugs. Urinary tract infections (UTIs) are a significant concern for these patients, and antibiotic prophylaxis is frequently used even if it is still a debated topic of literature. The purpose of this paper is to investigate the role and the real effectiveness of antibiotic prophylaxis in the reduction of incidence of UTIs in patients with spina bifida performing CIC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected data of all patients performing CIC, who did their last follow-up visit in the period between January 2019 and January 2021, followed at the children multidisciplinary Spina Bifida Center of A. Gemelli Hospital in Rome. Data collected included age at referral, gender, type of SD lesion, serum creatinine and cystatin C levels, the use of anticholinergic medications, antibiotic prophylaxis and type of prophylaxis (oral\/endovesical), age of starting prophylaxis with its duration\/adherence, number of CIC\/day and its duration, episodes of UTIs in the 2\u00a0years prior to the last follow-up, and presence and grade of vesical-ureteric reflux (VUR) on cystourethrogram.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 121 patients with SD performing CIC was included in the study; 66 (54%) presented\u2009\u2265\u20091 episode of UTIs in the last two years and 55 (46%) none. During the study period, 85 (70%) patients received antibiotic prophylaxis (ABP group) and 36 (30%) did not (NABP group): no statistically significative difference in terms of UTI development was observed between the two groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.17).\u00a0We also evaluated compliance to the therapy; 71 patients (59%) took antibiotic prophylaxis constantly (CABP group) and 50 (41%) did not do antibiotic prophylaxis constantly or did not do antibiotic prophylaxis at all (NCABP group): we observed a statistically significative difference in terms of UTIs with a 2.2 times higher risk of development at least one episode of UTIs in NCABP group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In conclusion, antibiotic prophylaxis performed constantly, without interruption, is associated with a lower risk of developing urinary tract infections and consequently to develop renal failure in adulthood.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00381-021-05337-y","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T20:02:30Z","timestamp":1631649750000},"page":"605-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of constant antibiotic prophylaxis in children affected by spinal dysraphism performing clean intermittent catheterization: a 2-year monocentric retrospective analysis"],"prefix":"10.1007","volume":"38","author":[{"given":"Francesco","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Ausili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Curatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rendeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"5337_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1726-4901(08)70158-8","volume":"71","author":"CK Chang","year":"2008","unstructured":"Chang CK, Wong TT, Huang BS, Chan RC, Yang TF (2008) Spinal dysraphism: a cross-sectional and retrospective multidisciplinary clinic-based study. J Chin Med Assoc 71:502\u2013508. https:\/\/doi.org\/10.1016\/S1726-4901(08)70158-8","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"5337_CR2","doi-asserted-by":"publisher","first-page":"15007","DOI":"10.1038\/nrdp.2015.7","volume":"2015","author":"AJ Copp","year":"2015","unstructured":"Copp AJ, Adzick NS, Chitty LS, Fletcher JM, Holmbeck GN, Shaw GM (2015) Spina bifida Nat Rev Dis Primers 2015(1):15007. https:\/\/doi.org\/10.1038\/nrdp.2015.7","journal-title":"Spina bifida Nat Rev Dis Primers"},{"key":"5337_CR3","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00381-013-2179-4","volume":"29","author":"G Tamburrini","year":"2013","unstructured":"Tamburrini G, Frassanito P, Iakovaki K, Pignotti F, Rendeli C, Murolo D et al (2013) Myelomeningocele: the management of the associated hydrocephalus. Childs Nerv Syst 29:1569\u20131579. https:\/\/doi.org\/10.1007\/s00381-013-2179-4","journal-title":"Childs Nerv Syst"},{"key":"5337_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11255-010-9894-5","volume":"44","author":"G Filler","year":"2012","unstructured":"Filler G, Gharib M, Casier S, L\u00f6dige P, Ehrich JH, Dave S (2012) Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol 44:817\u2013827. https:\/\/doi.org\/10.1007\/s11255-010-9894-5","journal-title":"Int Urol Nephrol"},{"key":"5337_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.juro.2015.03.107","volume":"194","author":"DC Snow-Lisy","year":"2015","unstructured":"Snow-Lisy DC, Yerkes EB, Cheng EY (2015) Update on urological management of spina bifida from prenatal diagnosis to adulthood. J Urol 194:288\u2013296. https:\/\/doi.org\/10.1016\/j.juro.2015.03.107","journal-title":"J Urol"},{"key":"5337_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00467-008-0780-7","volume":"23","author":"TP De Jong","year":"2008","unstructured":"De Jong TP, Chrzan R, Klijn AJ, Dik P (2008) Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol 23:889\u2013896. https:\/\/doi.org\/10.1007\/s00467-008-0780-7","journal-title":"Pediatr Nephrol"},{"key":"5337_CR7","doi-asserted-by":"publisher","unstructured":"Sutherland RS, Mevorach RA, Baskin LS, Kogan BA (1995) Spinal dysraphism in children: an overview and an approach to prevent complications. Urology 46(3):294-304. https:\/\/doi.org\/10.1016\/S0090-4295(99)80210-6. PMID: 7660503","DOI":"10.1016\/S0090-4295(99)80210-6"},{"key":"5337_CR8","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.juro.2016.07.081","volume":"196","author":"JC Routh","year":"2016","unstructured":"Routh JC, Cheng EY, Christopher Austin J, Baum MA, Gargollo PC, Grady RW et al (2016) Design and methodological considerations of the Centers for Disease Control and Prevention urologic and renal protocol for the newborn and young child with spina bifida. J Urol 196:1728\u20131734. https:\/\/doi.org\/10.1016\/j.juro.2016.07.081","journal-title":"J Urol"},{"key":"5337_CR9","doi-asserted-by":"publisher","unstructured":"Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D (2013) Urinary tract infections caused by community-acquired extendedspectrum \u03b2-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr 163(5):1417-1421. https:\/\/doi.org\/10.1016\/j.jpeds.2013.06.078. Epub 2013 Aug 3. PMID: 23919903","DOI":"10.1016\/j.jpeds.2013.06.078"},{"key":"5337_CR10","doi-asserted-by":"publisher","unstructured":"Ilic K, Jakovljevic E, Skodric-Trifunovic V (2012) Social economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare. Eur J Pediatr 171:767\u2013777. https:\/\/doi.org\/10.1007\/s00431-011-1592-5.","DOI":"10.1007\/s00431-011-1592-5"},{"key":"5337_CR11","doi-asserted-by":"publisher","unstructured":"Shepherd AK, Pottinger PS (2013) Management of urinary tract infections in the era of increasing antimicrobial resistance. Med Clin North Am 97(4):737-57, xii. https:\/\/doi.org\/10.1016\/j.mcna.2013.03.006. Epub 2013 Apr 29. PMID: 23809723","DOI":"10.1016\/j.mcna.2013.03.006"},{"key":"5337_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijantimicag.2011.09.006","volume":"38","author":"R Beetz","year":"2011","unstructured":"Beetz R, Westenfelder M (2011) Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents 38:42\u201350. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.09.006","journal-title":"Int J Antimicrob Agents"},{"key":"5337_CR13","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.juro.2011.07.108","volume":"186","author":"B Zegers","year":"2011","unstructured":"Zegers B, Uiterwaal C, Kimpen J, van Gool J, de Jong T, Winkler-Seinstra P et al (2011) Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. J Urol 186:2365\u20132370. https:\/\/doi.org\/10.1016\/j.juro.2011.07.108","journal-title":"J Urol"},{"key":"5337_CR14","doi-asserted-by":"publisher","first-page":"444.e1","DOI":"10.1016\/j.jpurol.2018.03.017","volume":"14","author":"TK Ortiz","year":"2018","unstructured":"Ortiz TK, Velazquez N, Ding L, Routh JC, Wiener JS, Seed PC et al (2018) Predominant bacteria and patterns of antibiotic susceptibility in urinary tract infection in children with spina bifida. J Pediatr Urol 14:444.e1-444.e8. https:\/\/doi.org\/10.1016\/j.jpurol.2018.03.017","journal-title":"J Pediatr Urol"},{"key":"5337_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.20136","volume":"53","author":"L Masini","year":"2019","unstructured":"Masini L, De Luca C, Noia G, Caruso A, Lanzone A, Rendeli C et al (2019) Prenatal diagnosis, natural history, postnatal treatment and outcome of 222 cases of spina bifida: experience of a tertiary center. Ultrasound Obstet Gynecol 53:302\u2013308. https:\/\/doi.org\/10.1002\/uog.20136","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5337_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ucl.2015.05.006","volume":"42","author":"MJ McKibben","year":"2015","unstructured":"McKibben MJ, Seed P, Ross SS, Borawski KM (2015) Urinary tract infection and neurogenic bladder. Urol Clin North Am 42:527\u2013536. https:\/\/doi.org\/10.1016\/j.ucl.2015.05.006","journal-title":"Urol Clin North Am"},{"key":"5337_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00467-008-1067-8","volume":"24","author":"BS Zegers","year":"2009","unstructured":"Zegers BS, Winkler-Seinstra PL, Uiterwaal CS, de Jong TV, Kimpen JL, de Jong-de Vos van Steenwijk CC (2009) Urinary tract infections in children with spina bifida: an inventory of 41 European centers. Pediatr Nephrol 24:783\u2013788. https:\/\/doi.org\/10.1007\/s00467-008-1067-8","journal-title":"Pediatr Nephrol"},{"key":"5337_CR18","doi-asserted-by":"publisher","unstructured":"Tradewell M, Pariser JJ, Nimeh T, Elliott SP, Neurogenic Bladder Research Group (2018) Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida. Transl Androl Urol 7:S205-S219. https:\/\/doi.org\/10.21037\/tau.2018.04.21","DOI":"10.21037\/tau.2018.04.21"},{"key":"5337_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jpedsurg.2004.11.027","volume":"40","author":"SA Clarke","year":"2005","unstructured":"Clarke SA, Samuel M, Boddy SA (2005) Are prophylactic antibiotics necessary with clean intermittent catheterization? A randomized controlled trial. J Pediatr Surg 40:568\u2013571. https:\/\/doi.org\/10.1016\/j.jpedsurg.2004.11.027","journal-title":"J Pediatr Surg"},{"key":"5337_CR20","doi-asserted-by":"publisher","unstructured":"Wallis MC, Paramsothy P, Newsome K, Williams T, Routh JC, Joseph DB et al (2021) Incidence of urinary tract infections in newborns with spina bifida: is antibiotic prophylaxis necessary?. The Journal of Urology 206:126\u2013132. https:\/\/doi.org\/10.1097\/JU.0000000000001690","DOI":"10.1097\/JU.0000000000001690"},{"key":"5337_CR21","doi-asserted-by":"publisher","unstructured":"Zegers SH, Dieleman J, van der Bruggen T, Kimpen J, de Jong-de Vos van Steenwijk C (2017) The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida. BMC Infect Dis 17:63. https:\/\/doi.org\/10.1186\/s12879-016-2166-y","DOI":"10.1186\/s12879-016-2166-y"},{"key":"5337_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22240","volume":"22","author":"R Pickard","year":"2018","unstructured":"Pickard R, Chadwick T, Oluboyede Y, Brennand C, von Wilamowitz-Moellendorff A, McClurg D et al (2018) Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT. Health Technology Assessment 22:1\u2013102. https:\/\/doi.org\/10.3310\/hta22240","journal-title":"Health Technology Assessment"},{"issue":"11","key":"5337_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2215\/CJN.05210515","volume":"7","author":"TK Mattoo","year":"2016","unstructured":"Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R et al (2016) Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) trial. Clin J Am Soc Nephrol 7(11):54\u201361. https:\/\/doi.org\/10.2215\/CJN.05210515","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-021-05337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-021-05337-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-021-05337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T19:05:11Z","timestamp":1647025511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-021-05337-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["5337"],"URL":"https:\/\/doi.org\/10.1007\/s00381-021-05337-y","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ID No. 3218 (2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests, or other interests that might be perceived to influence the interpretation of the article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}